Bart Deplancke Email and Phone Number
Bart Deplancke work email
- Valid
- Valid
- Valid
- Valid
Bart Deplancke personal email
Bart Deplancke graduated as a Biochemical Engineer at Ghent University (Belgium, 1998) after which he pursued doctoral studies in Immunobiology at the University of Illinois (USA) and postdoctoral work in regulatory genomics at the Harvard and UMass Medical Schools. In 2007, he established his lab at the EPFL School of Life Sciences where he is now a Full Professor and Vice-Dean of Innovation and is developing new, often single cell-related technologies to study how genomic variation mediates phenotypic diversity, especially in a metabolic context. These efforts allowed his group to for example discover a new anti-adipogenic stromal cell type as well as a new genomic concept, chromatin modules, that rationalize gene regulation in 3D. In 2013, he became a Swiss Institute of Bioinformatics Group Leader, in 2017, he was elected to the National Research Council of the Swiss National Science Foundation, in 2021, he received the Cloëtta Prize for outstanding contributions to biomedical research, and in 2022, the Leenaards Prize for Biomedical Translational Research. He is also the co-founder of two Biotech companies (Genohm, Acquired by Agilent in 2018; and Alithea Genomics).
-
Full ProfessorEpfl (École Polytechnique Fédérale De Lausanne)Lausanne, Vd, Ch
-
Vice Dean Of InnovationEpfl (École Polytechnique Fédérale De Lausanne) Sep 2018 - PresentLausanneResponsible for translational activities at the EPFL School of Life Sciences, including Catalyze for Life
-
Full ProfessorEpfl (École Polytechnique Fédérale De Lausanne) Jan 2020 - PresentLausanne Area, Switzerland
-
Co-FounderAlithea Genomics Apr 2020 - PresentLausanne, Vaud, SwitzerlandHigh throughput transcriptomics.Made simple. -
Group LeaderSib Swiss Institute Of Bioinformatics 2013 - PresentSystems and regulatory genomics -
Associate ProfessorEcole Polytechnique Fédérale De Lausanne (Epfl) Oct 2014 - Dec 2019Systems and regulatory genomics / Single cell / Computational Biology / Adipose Biology / Stem Cells
-
Board MemberGenohm Apr 2011 - May 2018Lausanne Area, SwitzerlandBoard Member until Genohm was acquired by Agilent Technologies in May 2018 -
Chairman Of The BoardGenohm Jan 2016 - Dec 2016
-
Assistant ProfessorEpfl Nov 2007 - Sep 2014Regulatory genomics and systems genetics
-
Post-DocUmass Medical School May 2003 - Aug 2007Post-doc in the lab of Dr. Marian Walhout studying gene regulatory networks in C. elegans -
Post-DocHarvard Medical School Sep 2002 - May 2003Large.scale protein-DNA interaction screening -
Biomedical Engineering Kind Baudouin FellowshipBelgian American Educational Foundation, Inc. 2002 - 2003Postdoctoral fellow at the Dana-Farber Cancer Institute (Harvard Medical School)
Bart Deplancke Skills
Bart Deplancke Education Details
-
Immunobiology, Molecular Biology, Microbiology -
Biochemistry, Engineering
Frequently Asked Questions about Bart Deplancke
What company does Bart Deplancke work for?
Bart Deplancke works for Epfl (École Polytechnique Fédérale De Lausanne)
What is Bart Deplancke's role at the current company?
Bart Deplancke's current role is Full Professor.
What is Bart Deplancke's email address?
Bart Deplancke's email address is ba****@****med.edu
What schools did Bart Deplancke attend?
Bart Deplancke attended University Of Illinois Urbana-Champaign, Ghent University.
What skills is Bart Deplancke known for?
Bart Deplancke has skills like Genetics, Genomics, Molecular Biology, Bioinformatics, Cell Biology, Biochemistry, Systems Biology, Computational Biology, Molecular Cloning, Cell Culture, Sequencing, Scientific Writing.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial